Biodesy nabs $15 mln in Series A financing, also appoints new CEO
Biodesy said Thursday that it has secured $15 million in Series A financing. Investors included 5AM Ventures, Pfizer Venture Investments and Roche Venture Fund. Also, the company has named Greg Yap as CEO and a director. Based in Burlingame, Calif., Biodesy is a provider of real-time protein function analysis for research and clinical applications.
17 October 2013•3 mins read
